D - Amp M Pharma Peru Sac

A line of pressurized inhaler suspensions (200 mcg and combination formulas) designed for air passage inflammation.

: Tablets and supplements such as Niacider (500 mg) and Recuplus targeted for nutritional and continuous therapeutic care.

The Peruvian pharmaceutical distribution market is moderately concentrated, with major players like , MiFarma , and Corbeta dominating retail. However, D amp M Pharma Peru SAC occupies a valuable niche: institutional and sub-distribution .

Beyond pharmaceuticals, the company distributes surgical sutures, diagnostic strips, and personal protective equipment (PPE), a segment that grew exponentially after the COVID-19 pandemic. d amp m pharma peru sac

DIGEMID - General Directorate of Medicines, Supplies and Drugs

: Covers dermatology, respiratory, and biotechnology lines.

Formulations utilized for bronchodilation and targeted nasal/nebulized delivery architectures. 3. Ophthalmological and Specialized Care A line of pressurized inhaler suspensions (200 mcg

For healthcare buyers: Always cross-reference their RUC, DIGEMID permits, and physical warehouse location before signing contracts. For investors: The "SAC" structure offers limited liability, but due diligence on their import volumes via SUNAT’s Perfil de Riesgo is mandatory.

Unlike broad wholesale distributors, D & M Pharma has carved out a niche in respiratory health.

: Includes biotechnology and specialized probiotic treatments like to support intestinal flora. D&M Pharma Recent Developments and Leadership However, D amp M Pharma Peru SAC occupies

The pharmaceutical market in Peru presents unique challenges, ranging from complex logistics to diverse demographic needs. D&M Pharma Peru S.A.C. differentiates itself through a strategic commercialization model. Rather than a "one-size-fits-all" approach, the company leverages deep market intelligence to position products effectively.

As continues to grow, its commitment to science, quality, and service remains central to its operations. Through a focus on medical updates and supporting healthcare professionals, the company plays a vital role in improving patient outcomes in Peru.

: Detailed business profiles, including financial data from 2022 and employee counts, are available through platforms like EMIS (D & M Pharma Peru S.A.C. Profile) .